(Q44861450)

6 December 2017

title

Almotriptan improves response rates when treatment is within 1 hour of migraine onset (English)

1 reference

6 December 2017

1 reference

Dowson AJ

1

1 reference

6 December 2017

Massiou H

series ordinal

2

1 reference

6 December 2017

Lainez JM

series ordinal

3

1 reference

6 December 2017

Cabarrocas X

series ordinal

4

1 reference

6 December 2017

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

44

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

318-322

1 reference

Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Integrating the triptans into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

Clinical benefits of early triptan therapy for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04074.X

10.1111/J.1526-4610.2004.04074.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference